978 related articles for article (PubMed ID: 8859175)
41. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
[TBL] [Abstract][Full Text] [Related]
42. Pilot study of multiple-fraction daily radiotherapy alternating with chemotherapy in patients with stage IV non-oat cell lung cancer.
Arcangeli G; Righini R; Nervi C; Guerra A; Tirindelli D; Hopkins H; Looney W
Cancer Treat Rep; 1985 Jan; 69(1):25-31. PubMed ID: 2981618
[TBL] [Abstract][Full Text] [Related]
43. Management for patients with advanced T4 epidermoid carcinoma of the esophagus.
Wang LS; Chi KH; Hu MH; Fahn HJ; Huang MH
J Surg Oncol; 1996 May; 62(1):22-9. PubMed ID: 8618396
[TBL] [Abstract][Full Text] [Related]
44. Chemotherapy for advanced non-small cell lung cancer.
Ichinose Y; Takanashi N; Yano T; Asoh H; Yokoyama H; Tayama K; Hara N; Ohta M
Natl Med J India; 1996; 9(1):24-5. PubMed ID: 8713521
[TBL] [Abstract][Full Text] [Related]
45. Concurrent chemotherapy and radiation therapy for locally advanced carcinoma of the esophagus.
Ohtsu A; Yoshida S; Boku N; Fujii T; Miyata Y; Hosokawa K; Koba I; Shimizu W; Ogino T
Jpn J Clin Oncol; 1995 Dec; 25(6):261-6. PubMed ID: 8523823
[TBL] [Abstract][Full Text] [Related]
46. [Inoperable cancer of the esophagus: preliminary results of combined chemotherapy (5-fluorouracil-cisplatin) and radiotherapy].
Seitz JF; Padaut-Cesana J; Fuentes P; Giudicelli R; Giovannini M; Gauthier A; Reboud E
Gastroenterol Clin Biol; 1988 Oct; 12(10):736-42. PubMed ID: 3065123
[TBL] [Abstract][Full Text] [Related]
47. Chemotherapy and extended-field radiation therapy to para-aortic area in patients with histologically proven metastatic cervical cancer to para-aortic nodes: a phase II pilot study.
Husseinzadeh N; Shrake P; DeEulis T; Rowley K; Aron B
Gynecol Oncol; 1994 Mar; 52(3):326-31. PubMed ID: 8157190
[TBL] [Abstract][Full Text] [Related]
48. [Combined radiotherapy and pre-radiation chemotherapy with cisplatin and 5-fluorouracil for advanced esophageal carcinoma. II. Clinical evaluation in cases with higher than T2 stage].
Sueyama H
Nihon Gan Chiryo Gakkai Shi; 1990 Aug; 25(8):1608-18. PubMed ID: 2230444
[TBL] [Abstract][Full Text] [Related]
49. Inoperable esophageal carcinoma: results of aggressive synchronous radiotherapy and chemotherapy. A pilot study.
John M; Flam M; Wittlinger P; Mowry PA
Am J Clin Oncol; 1987 Aug; 10(4):310-6. PubMed ID: 2441591
[TBL] [Abstract][Full Text] [Related]
50. A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma.
Lee J; Im YH; Cho EY; Hong YS; Lee HR; Kim HS; Kim MJ; Kim K; Kang WK; Park K; Shim YM
Cancer Chemother Pharmacol; 2008 Jun; 62(1):77-84. PubMed ID: 17762932
[TBL] [Abstract][Full Text] [Related]
51. Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japanese Esophageal Oncology Group Trial.
Iizuka T; Kakegawa T; Ide H; Ando N; Watanabe H; Tanaka O; Takagi I; Isono K; Ishida K; Arimori M
Jpn J Clin Oncol; 1992 Jun; 22(3):172-6. PubMed ID: 1518165
[TBL] [Abstract][Full Text] [Related]
52. Phase II study of cisplatin, 5-FU, and allopurinol in advanced esophageal cancer.
De Besi P; Sileni VC; Salvagno L; Tremolada C; Cartei G; Fosser V; Paccagnella A; Peracchia A; Fiorentino M
Cancer Treat Rep; 1986 Jul; 70(7):909-10. PubMed ID: 2424595
[TBL] [Abstract][Full Text] [Related]
53. Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposide.
Joss RA; Alberto P; Obrecht JP; Barrelet L; Holdener EE; Siegenthaler P; Goldhirsch A; Mermillod B; Cavalli F
Cancer Treat Rep; 1984 Sep; 68(9):1079-84. PubMed ID: 6090014
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of concurrent chemoradiotherapy as a palliative treatment in stage IVB esophageal cancer patients with dysphagia.
Ikeda E; Kojima T; Kaneko K; Minashi K; Onozawa M; Nihei K; Fuse N; Yano T; Yoshino T; Tahara M; Doi T; Ohtsu A
Jpn J Clin Oncol; 2011 Aug; 41(8):964-72. PubMed ID: 21742654
[TBL] [Abstract][Full Text] [Related]
55. Weekly chemotherapy with cisplatin and paclitaxel and concurrent radiation therapy as preoperative treatment in locally advanced esophageal cancer: a phase II study.
Orditura M; Galizia G; Napolitano V; Martinelli E; Pacelli R; Lieto E; Aurilio G; Vecchione L; Morgillo F; Catalano G; Ciardiello F; Del Genio A; Di Martino N; De Vita F
Cancer Invest; 2010 Oct; 28(8):820-7. PubMed ID: 20482249
[TBL] [Abstract][Full Text] [Related]
56. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin.
Gershenson DM; Morris M; Burke TW; Levenback C; Matthews CM; Wharton JT
Obstet Gynecol; 1996 Apr; 87(4):527-31. PubMed ID: 8602303
[TBL] [Abstract][Full Text] [Related]
57. Neoadjuvant chemotherapy with etoposide, leucovorin, 5-fluorouracil and cisplatin for advanced esophageal squamous cell carcinoma.
Ohwada S; Nakamura S; Izumi M; Kawashima Y; Ogawa T; Kobayashi I; Hosomura Y; Joshita T; Lino Y; Morishita Y
Jpn J Clin Oncol; 1995 Jun; 25(3):79-85. PubMed ID: 7596052
[TBL] [Abstract][Full Text] [Related]
58. Cisplatin, high dose folinic acid and 5-fluorouracil in squamous cell carcinoma of the esophagus. A pilot study.
Zaniboni A; Simoncini E; Tonini G; Pezzola D; Farfaglia R; Lancini GP; Marpicati P; Montini E; Marini G
Chemioterapia; 1987 Dec; 6(6):387-9. PubMed ID: 3501732
[TBL] [Abstract][Full Text] [Related]
59. Radiotherapy with or without concurrent chemotherapy for lymph node recurrence after radical surgery of thoracic esophageal squamous cell carcinoma.
Lu JC; Kong C; Tao H
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):710-4. PubMed ID: 20172661
[TBL] [Abstract][Full Text] [Related]
60. Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas.
Iwasa S; Morizane C; Okusaka T; Ueno H; Ikeda M; Kondo S; Tanaka T; Nakachi K; Mitsunaga S; Kojima Y; Hagihara A; Hiraoka N
Jpn J Clin Oncol; 2010 Apr; 40(4):313-8. PubMed ID: 20047862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
